Specific Cytotoxic Effect of an Auristatin Nanoconjugate Towards CXCR4+ Diffuse Large B-Cell Lymphoma Cells

Código QR

Specific Cytotoxic Effect of an Auristatin Nanoconjugate Towards CXCR4+ Diffuse Large B-Cell Lymphoma Cells

Aïda Falgàs,1– 3 Victor Pallarès,1– 3 Ugutz Unzueta,1– 4 Yáiza Núñez,1,2 Jorge Sierra,2,5 Alberto Gallardo,1 Lorena Alba-Castellón,1,2 Maria Antonia Mangues,3,6 Patricia Álamo,1&nd...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Falgàs A, Pallarès V, Unzueta U, Núñez Y, Sierra J, Gallardo A, Alba-Castellón L, Mangues MA, Álamo P, Villaverde A, Vázquez E, Mangues R, Casanova I
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	nanomedicine targeted drug delivery mmae dlbcl Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/ad15fac8734d44d5b70ee95f4190a782
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Patient-Specific Modeling of Diffuse Large B-Cell Lymphoma
por: Kirsten Thobe, et al.
Publicado: (2021)

Intracellular CXCR4+ cell targeting with T22-empowered protein-only nanoparticles
por: Unzueta U, et al.
Publicado: (2012)

Prognostic significance of pretreatment serum free fatty acid in patients with diffuse large B-cell lymphoma in the rituximab era: a retrospective analysis
por: Liping Fan, et al.
Publicado: (2021)

Antibacterial Activity of T22, a Specific Peptidic Ligand of the Tumoral Marker CXCR4
por: Naroa Serna, et al.
Publicado: (2021)

Tumor cell-derived IL-10 promotes cell-autonomous growth and immune escape in diffuse large B-cell lymphoma
por: Kristin Stirm, et al.
Publicado: (2021)

Influence of <i>TP53</i> Mutation on Survival of Diffuse Large B-Cell Lymphoma in the CAR T-Cell Era
por: Edit Porpaczy, et al.
Publicado: (2021)

Impact of Cell-of-Origin on Outcome of Patients With Diffuse Large B-Cell Lymphoma Treated With Uniform R-CHOP Protocol: A Single-Center Retrospective Analysis From North India
por: Ajay Gogia, et al.
Publicado: (2021)

Universal extracellular vesicles and PD-L1+ extracellular vesicles detected by single molecule array technology as circulating biomarkers for diffuse large B cell lymphoma
por: Ji-Wei Li, et al.
Publicado: (2021)

Nanomedicine journal

Journal of Interdisciplinary nanomedicine

European journal of nanomedicine

Proteomic Profiling Differentiates Lymphoma Patients with and without Concurrent Myeloproliferative Neoplasia
por: Johanne Marie Holst, et al.
Publicado: (2021)

Immunotherapy for Diffuse Large B-Cell Lymphoma: Current Landscape and Future Directions
por: Dipenkumar Modi, et al.
Publicado: (2021)

In vitro cytotoxicity of GO–DOx on FaDu squamous carcinoma cell lines
por: Singh M, et al.
Publicado: (2018)

Ion-dependent slow protein release from in vivo disintegrating micro-granules
por: Patricia Álamo, et al.
Publicado: (2021)

ASB2 is a direct target of FLI1 that sustains NF-κB pathway activation in germinal center-derived diffuse large B-cell lymphoma
por: Giulio Sartori, et al.
Publicado: (2021)

Efficacy and Safety of Innovative Experimental Chimeric Antigen Receptor (CAR) T-cells versus Axicabtagene ciloleucel (Yescarta) for the Treatment of Relapsed/Refractory Large B-Cell Lymphoma (LBCL): Matching Adjusted Indirect Comparisons (MAICs) and Systematic Review
por: Bayarmagnai Weinstein, et al.
Publicado: (2021)

High Ki67 proliferation index but not cell-of-origin subtypes is associated with shorter overall survival in diffuse large B-cell lymphoma
por: Feras Zaiem, et al.
Publicado: (2020)

Promising self-emulsifying drug delivery system loaded with lycopene from red guava (Psidium guajava L.): in vivo toxicity, biodistribution and cytotoxicity on DU-145 prostate cancer cells
por: Andreanne G. Vasconcelos, et al.
Publicado: (2021)

EVT‐701 is a novel selective and safe mitochondrial complex 1 inhibitor with potent anti‐tumor activity in models of solid cancers
por: Raquel Luna Yolba, et al.
Publicado: (2021)

CXCR5 CAR-T cells simultaneously target B cell non-Hodgkin’s lymphoma and tumor-supportive follicular T helper cells
por: Mario Bunse, et al.
Publicado: (2021)

Nanoinformatics: an emerging area of information technology at the intersection of bioinformatics, computational chemistry and nanobiotechnology
por: González-Nilo,Fernando, et al.
Publicado: (2011)

Overcoming tumor cell chemoresistance using nanoparticles: lysosomes are beneficial for (stearoyl) gemcitabine-incorporated solid lipid nanoparticles
por: Chen Z, et al.
Publicado: (2018)

Impact of the Nuclear Envelope on Malignant Transformation, Motility, and Survival of Lung Cancer Cells
por: Sílvio Terra Stefanello, et al.
Publicado: (2021)

Inhibitory effect of Au@Pt-NSs on proliferation, migration, and invasion of EJ bladder carcinoma cells: involvement of cell cycle regulators, signaling pathways, and transcription factor-mediated MMP-9 expression
por: Shin SS, et al.
Publicado: (2018)

Lysyl oxidase activates cancer stromal cells and promotes gastric cancer progression: quantum dot-based identification of biomarkers in cancer stromal cells
por: Peng CW, et al.
Publicado: (2017)

Research Progress on Cell Membrane-Coated Biomimetic Delivery Systems
por: Mengyu Guo, et al.
Publicado: (2021)

In vitro determination of the efficacy of scorpion venoms as anti-cancer agents against colorectal cancer cells: a nano-liposomal delivery approach
por: Al-Asmari AK, et al.
Publicado: (2017)

Is small smarter? Nanomaterial-based detection and elimination of circulating tumor cells: current knowledge and perspectives
por: Gribko A, et al.
Publicado: (2019)

Curcumin Ag nanoconjugates for improved therapeutic effects in cancer
por: Shah D, et al.
Publicado: (2018)

Use of Biocompatible Sorafenib-gold Nanoconjugates for Reversal of Drug Resistance in Human Hepatoblatoma Cells
por: Sandeep Kumar Vishwakarma, et al.
Publicado: (2017)

Medicine embraces nano: diagnostics to delivery
por: Singh SP, et al.
Publicado: (2018)

A nanoconjugate Apaf-1 inhibitor protects mesothelial cells from cytokine-induced injury.
por: Beatriz Santamaría, et al.
Publicado: (2009)

Self-Assembled DNA Nanostructure as a Carrier for Targeted siRNA Delivery in Glioma Cells
por: Zhou Y, et al.
Publicado: (2021)

CNS Prophylaxis: How Far Is Routine Practice From the Guidelines? Focus on a Nationwide Survey by the Fondazione Italiana Linfomi (FIL)
por: Guido Gini, et al.
Publicado: (2021)

Radiolabeling, whole-body single photon emission computed tomography/computed tomography imaging, and pharmacokinetics of carbon nanohorns in mice
por: Zhang M, et al.
Publicado: (2016)

Target Nanoparticles against Pancreatic Cancer: Fewer Side Effects in Therapy
por: Jorge A. Roacho-Pérez, et al.
Publicado: (2021)

PD-L1 monoclonal antibody-conjugated nanoparticles enhance drug delivery level and chemotherapy efficacy in gastric cancer cells
por: Xu S, et al.
Publicado: (2018)

Transferrin-functionalized nanographene oxide for delivery of platinum complexes to enhance cancer-cell selectivity and apoptosis-inducing efficacy
por: Zhu H, et al.
Publicado: (2017)

Cuprous oxide nanoparticles inhibit prostate cancer by attenuating the stemness of cancer cells via inhibition of the Wnt signaling pathway
por: Wang Y, et al.
Publicado: (2017)